Kailera Therapeutics, Inc. Common Stock (KLRA) — Net Asset Momentum
Kailera Therapeutics, Inc. Common Stock (KLRA) recorded a net asset momentum of -62.9% as of December 2025, with net assets of $-356.46 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Kailera Therapeutics, Inc. Common Stock (KLRA) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Kailera Therapeutics, Inc. Common Stock Net Asset Momentum (2024–2025)
This chart tracks Kailera Therapeutics, Inc. Common Stock's year-over-year net asset growth across 2 annual reporting periods from 2024 to 2025. The most recent momentum reading is -62.9%, with net assets of $-356.46 Million USD as of December 2025. For live market cap and overall valuation, see market cap of Kailera Therapeutics, Inc. Common Stock.
Annual Net Asset History for Kailera Therapeutics, Inc. Common Stock (2024–2025)
The table below shows the complete annual net asset history for Kailera Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check KLRA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $-356.46 Million | $692.29 Million | $1.05 Billion | ▼ -62.9% |
| 2024 | $-218.77 Million | $178.44 Million | $397.22 Million | — |